CCMH
REGN icon

Cornerstone Capital Management Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$5.45M Buy
14,483
+1,294
+10% +$524K 0.04% 428
2017
Q3 		$5.9M Buy
13,189
+77
+0.6% +$36.6K 0.05% 388
2017
Q2 		$6.44M Sell
13,112
-40
-0.3% -$17.5K 0.05% 375
2017
Q1 		$5.1M Sell
13,152
-31
-0.2% -$11.5K 0.04% 457
2016
Q4 		$4.84M Sell
13,183
-1,086
-8% -$413K 0.04% 482
2016
Q3 		$5.74M Sell
14,269
-2,533
-15% -$1.02M 0.04% 434
2016
Q2 		$5.87M Sell
16,802
-92
-0.5% -$35.4K 0.05% 417
2016
Q1 		$6.09M Sell
16,894
-293
-2% -$121K 0.05% 404
2015
Q4 		$9.33M Sell
17,187
-227
-1% -$123K 0.08% 285
2015
Q3 		$8.1M Sell
17,414
-765
-4% -$411K 0.08% 301
2015
Q2 		$9.27M Buy
18,179
+1,178
+7% +$575K 0.08% 275
2015
Q1 		$7.67M Sell
17,001
-1,032
-6% -$437K 0.07% 334
2014
Q4 		$7.4M Buy
18,033
+1,494
+9% +$588K 0.08% 342
2014
Q3 		$5.96M Sell
16,539
-1,459
-8% -$489K 0.06% 375
2014
Q2 		$5.08M Buy
17,998
+364
+2% +$108K 0.06% 418
2014
Q1 		$5.3M Sell
17,634
-1,156
-6% -$356K 0.06% 385
2013
Q4 		$5.17M Sell
18,790
-333
-2% -$95.8K 0.06% 394
2013
Q3 		$5.98M Sell
19,123
-5,005
-21% -$1.32M 0.07% 360
2013
Q2 		$5.43M Buy
+24,128
New +$5.62M 0.07% 358

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Cornerstone Capital Management Holdings's REGN Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 9.8% in Q4 2017, buying an estimated $524K and bringing the position to 14,483 shares worth $5.45M. The position accounts for 0.04% of the portfolio, ranked #428.

Cornerstone Capital Management Holdings first reported a position in REGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $9.33M in Q4 2015. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Cornerstone Capital Management Holdings held 14,483 shares of Regeneron Pharmaceuticals worth $5.45M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 1,294 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $524K.
  • Regeneron Pharmaceuticals made up 0.04% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #428 holding.
  • Cornerstone Capital Management Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Regeneron Pharmaceuticals position peaked at $9.33M in Q4 2015.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.